WALTHAM, Mass., Feb. 23, 2017-- Interleukin Genetics, Inc., a life sciences company focused on the genetics of chronic inflammation, announced today that it has entered into a relationship with mPulse ...
- GlobeNewswire•9 days agoInterleukin Genetics and Pittsburgh Business Group on Health Forge Relationship to Bring the ILUSTRA™ Inflammation Management Program to Pittsburgh Area Employers
WALTHAM, Mass., Feb. 15, 2017-- Interleukin Genetics, Inc., a life sciences company focused on the genetics of chronic inflammation, announced today that it has entered into a relationship with the Pittsburgh ...
- Capital Cube•3 months ago
Categories: Yahoo Finance Get free summary analysis Interleukin Genetics, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Interleukin Genetics, Inc. – Psychemedics Corporation, Genomic Health, Inc., RadNet, Inc., Quest Diagnostics Incorporated, Myriad Genetics, Inc. and Trovagene, Inc. (PMD-US, GHDX-US, RDNT-US, DGX-US, MYGN-US and TROV-US) that ... Read more (Read more...)
ILIU : Summary for INTERLEUKIN GENETICS - Yahoo Finance
Interleukin Genetics, Inc. (ILIU)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.10 - 0.11|
|52 Week Range||0.04 - 0.22|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-2.80|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|